MENU
ARVN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Arvinas (ARVN) Earnings Date & Reports

Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

ARVN is expected to report earnings to rise 3.23% to -49 cents per share on March 02

Arvinas ARVN Stock Earnings Reports
Q4'25
Est.
$-0.50
Q3'25
Beat
by $0.23
Q2'25
Beat
by $0.10
Q1'25
Beat
by $2.14
Q4'24
Beat
by $0.33
The last earnings report on November 05 showed earnings per share of -47 cents, beating the estimate of -70 cents. With 747.27K shares outstanding, the current market capitalization sits at 650.27M.
View a ticker or compare two or three
ARVN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ARVN showed earnings on November 05, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a developer of therapies to degrade disease-causing proteins

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
395 Winchester Avenue
Phone
+1 203 535-1456
Employees
445
Web
https://www.arvinas.com